[HTML][HTML] Surface plasmon resonance (SPR) sensor for cancer biomarker detection
A biomarker is a physiological observable marker that acts as a stand-in and, in the best-
case scenario, forecasts a clinically significant outcome. Diagnostic biomarkers are more …
case scenario, forecasts a clinically significant outcome. Diagnostic biomarkers are more …
[HTML][HTML] HE4 as a Biomarker for Endometrial Cancer
R Behrouzi, CE Barr, EJ Crosbie - Cancers, 2021 - mdpi.com
Simple Summary There are currently no blood biomarkers approved for routine clinical use
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …
in endometrial cancer. Serum human epididymis protein 4 (HE4) is significantly higher in …
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian …
Abstract Background: Updated National Academy of Clinical Biochemistry (NACB)
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
Laboratory Medicine Practice Guidelines for the use of tumor markers in the clinic have been …
[HTML][HTML] HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
T Van Gorp, I Cadron, E Despierre, A Daemen… - British journal of …, 2011 - nature.com
Background: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human
epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as …
epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as …
Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass
RG Moore, MC Miller, P Disilvestro… - Obstetrics & …, 2011 - journals.lww.com
OBJECTIVE: It is often difficult to distinguish a benign pelvic mass from a malignancy and
tools to help referring physician are needed. The purpose of this study was to validate the …
tools to help referring physician are needed. The purpose of this study was to validate the …
[HTML][HTML] Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K Huhtinen, P Suvitie, J Hiissa, J Junnila… - British journal of …, 2009 - nature.com
Human epididymal secretory protein E4 (HE4, also known as WAP four-disulphide core
domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against …
domain protein 2) is a new promising biomarker for ovarian cancer but its specificity against …
Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease
Abstract Learning Objectives After completing this course, the reader will be able to:
Describe the site-specific dysregulation of some miRNAs and explain their potential as non …
Describe the site-specific dysregulation of some miRNAs and explain their potential as non …
Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases
JM Escudero, JM Auge, X Filella, A Torne… - Clinical …, 2011 - academic.oup.com
BACKGROUND Human epididymis protein 4 (HE4), a precursor of human epididymis
protein, has been proposed as a tumor marker for ovarian cancer. We evaluated HE4 in …
protein, has been proposed as a tumor marker for ovarian cancer. We evaluated HE4 in …
[HTML][HTML] HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases
R Molina, JM Escudero, JM Augé, X Filella, L Foj… - Tumor Biology, 2011 - Springer
The aim of this study is to evaluate a new tumour marker, HE4, in comparison with CA 125
and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients …
and the Risk of Ovarian Malignancy Algorithm (ROMA) in healthy women and in patients …
Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review☆
DM Boruta II, PA Gehrig, AN Fader, AB Olawaiye - Gynecologic oncology, 2009 - Elsevier
OBJECTIVE: Uterine papillary serous carcinoma (UPSC) is a clinically and pathologically
distinct subtype of endometrial cancer. Although less common than its endometrioid …
distinct subtype of endometrial cancer. Although less common than its endometrioid …